Event JSON
{
"id": "11fb46bff46183cb9987629143b7f2a5ae8c4cadafb0872c499342f24da13716",
"pubkey": "2a615c749514e3fabb8adbef945539af0d32f7a467c0c844bf07305ec1367c35",
"created_at": 1719119118,
"kind": 1,
"tags": [
[
"p",
"ede28cfd46428a701f29e885e38c57894b52e56c25c616b7f45bed6bf4d63457",
"wss://relay.mostr.pub"
],
[
"p",
"811273807c5b6c43dffe4ea303c053e8863a8737c04b3f8669025361682b08d5",
"wss://relay.mostr.pub"
],
[
"e",
"e115c2819fac8ddbc17da7219f392aec1dca007fd84126ef7bc8acff73d3bb1f",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://poa.st/objects/7e2b21dd-90cb-4ea0-bf24-02ada30d5de8",
"activitypub"
]
],
"content": "don't worry! they're working tirelessly on important things to get that trust back\n\nhttps://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html",
"sig": "b8913793dd42de1902e9af3a45f011ca7657413783e51b63795f58b4bc61f72a59c2e8d76b8d61ef88b4685d4e64f55bb7361ce70ebb638310c75c4dd47ec4d0"
}
